US5508272A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Compounds containing a fused bicycle ring and processes therefor
Assignee: Bristol Myers Squibb Co
•
Filing: 1994-05-05
•
Granted: 1996-04-16
•
Expires: 2014-05-05
Abstract
Abstract Compounds of the formula <IMAGE> wherein X is O or S-(O)t; n is one or two; m is zero or one; Y is CH2, O, or S-(O)t provided that Y is O or S-(O)t only when m is one; and A is <IMAGE> are dual inhibitors of NEP and ACE. Compounds wherein A is <IMAGE> are selective ACE inhibitors. Also disclosed are methods of preparation and intermediates.
Inventors
- 👤 Jeffrey A. Robl
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 18:21
CPC Classifications
C; C07; C07D; C07D513/00; C07D513/02; C07D513/04; A; A61; A61P; A61P43/00; A61P9/00; A61P9/04; A61P9/12; C07C; C07C227/00; C07C227/30; C07C227/32; C07C315/00; C07C315/02; C07C319/00; C07C319/14; C07C319/20; C07C327/00; C07C327/20; C07C327/32; C07C327/34; C07D498/00; C07D498/02; C07D498/04; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/06139; A61K; A61K38/00; C07B; C07B2200/00; C07B2200/07; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55
Claims Analysis
Total Claims: 41
Claim 1
Independent Claim
321 words
A compound of the formula ##STR87## or a pharmaceutically acceptable salt thereof wherein: A is ##STR88## X is O or S-(O) t ; R 1 and R 12 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, substituted alkyl, substituted alkenyl, aryl, substituted aryl, heteroaryl, cycloalkyl- alkylene-, aryl-alkylene-, substituted aryl- alkylene-, and heteroaryl-alkylene- or R 1 and R 12 taken together with the carbon to which they are attached complete a cycloalkyl ring or a benzolused cycloalkyl ring; R 2 is hydrogen, ##STR89## or R 11 -S-; R 3 , R 5 and R 7 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl- (CH 2 ) p-, substituted aryl- (CH 2 ) p -, heteroaryl-(CH 2 ) p - , ##STR90## R 4 is alkyl, cycloalkyl-(CH 2 ) p -, substituted alkyl, aryl-(CH 2 ) p -, substituted aryl-(CH 2 ) p -, or heteroaryl-(CH 2 ) p -; R 6 is alkyl, substituted alkyl, cycloalkyl-(CH 2 ) p -, aryl- (CH 2 ) p -, substituted aryl-(CH 2 ) p -, or heteroaryl-(CH 2 ) p -; R 8 is hydrogen, lower alkyl, cycloalkyl, or phenyl; R 9 is hydrogen, lower alkyl, lower alkoxy, or phenyl; R 10 is lower alkyl or aryl-(CH 2 ) p -; R 11 is hydrogen, alkyl, substituted alkyl, cycloalkyl-(CH 2 ) p -, aryl- (CH 2 ) p -, substituted aryl-(CH 2 ) p -, heteroaryl-(CH 2 ) p -, or -S-R 11 completes a symmetrical disulfide wherein R 11 is ##STR91## m is zero or one; Y is CH 2 , S-(O) t or O provided that Y is S-(O) t or O only when m is one; n is one or two; p is zero or an integer from 1 to 6; q is zero or an integer from 1 to 3; r is zero or one; and t is zero, one, or two.
Claim 2
Dependent Claim
321 words
A compound of the formula ##STR87## or a pharmaceutically acceptable salt thereof wherein: A is ##STR88## X is O or S-(O) t ; R 1 and R 12 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, substituted alkyl, substituted alkenyl, aryl, substituted aryl, heteroaryl, cycloalkyl- alkylene-, aryl-alkylene-, substituted aryl- alkylene-, and heteroaryl-alkylene- or R 1 and R 12 taken together with the carbon to which they are attached complete a cycloalkyl ring or a benzolused cycloalkyl ring; R 2 is hydrogen, ##STR89## or R 11 -S-; R 3 , R 5 and R 7 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, aryl- (CH 2 ) p-, substituted aryl- (CH 2 ) p -, heteroaryl-(CH 2 ) p - , ##STR90## R 4 is alkyl, cycloalkyl-(CH 2 ) p -, substituted alkyl, aryl-(CH 2 ) p -, substituted aryl-(CH 2 ) p -, or heteroaryl-(CH 2 ) p -; R 6 is alkyl, substituted alkyl, cycloalkyl-(CH 2 ) p -, aryl- (CH 2 ) p -, substituted aryl-(CH 2 ) p -, or heteroaryl-(CH 2 ) p -; R 8 is hydrogen, lower alkyl, cycloalkyl, or phenyl; R 9 is hydrogen, lower alkyl, lower alkoxy, or phenyl; R 10 is lower alkyl or aryl-(CH 2 ) p -; R 11 is hydrogen, alkyl, substituted alkyl, cycloalkyl-(CH 2 ) p -, aryl- (CH 2 ) p -, substituted aryl-(CH 2 ) p -, heteroaryl-(CH 2 ) p -, or -S-R 11 completes a symmetrical disulfide wherein R 11 is ##STR91## m is zero or one; Y is CH 2 , S-(O) t or O provided that Y is S-(O) t or O only when m is one; n is one or two; p is zero or an integer from 1 to 6; q is zero or an integer from 1 to 3; r is zero or one; and t is zero, one, or two.
Claim 3
Dependent Claim
9 words
A compound of claim 1 having the formula ##STR92##
Claim 4
Dependent Claim
7 words
A compound of claim 2 wherein: ##STR93##
Claim 5
Dependent Claim
150 words
A compound of claim 3 wherein: R 2 is hydrogen, ##STR94## or R 11 -S-; R 3 is hydrogen or lower alkyl of 1 to 4 carbons; r is zero or one; R 11 is lower alkyl or 1 to 4 carbons; R 1 is aryl-CH 2 -, substituted aryl-CH 2 -, heteroaryl-CH 2 -, cycloalkyl-CH 2 - wherein cycloalkyl is of 3 to 7 carbons, or straight or branched chain alkyl of 1 to 7 carbons and R 12 is hydrogen; or R 1 and R 12 taken together with the carbon to which they are attached complete a cycloalkyl ring of 5 to 7 carbons; R 6 is lower alkyl of 1 to 4 carbons or phenyl; m is zero or one; X is O or S; and Y is CH 2 , O, or S provided that Y is O or S only when m is one.
Claim 6
Dependent Claim
72 words
A compound of claim 3 wherein: R 2 is hydrogen or ##STR95## R 3 is hydrogen; r is zero or one; R 1 is benzyl, cyclopropylmethyl, or straight or branched chain alkyl of 3 to 5 carbons; R 12 is hydrogen; m is zero or one; X is O or S; and Y is CH 2 , O, or S provided that Y is O or S only when m is one.
Claim 7
Dependent Claim
18 words
A compound of claim 5 wherein: X is S; Y is CH 2 ; m i s one.
Claim 8
Dependent Claim
22 words
A compound of claim 6 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 9
Dependent Claim
10 words
The compound of claim 7, [4S-[4α(R*) , 7α,10aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl) amino]-5-oxo-7H-pyrido[2,1-b][1,3]thia-zepine-7-carboxylic acid.
Claim 10
Dependent Claim
11 words
The compound of claim 7, [4S-[4β(R*), 7α, 10aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenyl-propyl) amino]-5-oxo-7H-pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid,1,1-dimethylethylamine salt.
Claim 11
Dependent Claim
10 words
The compound of claim 7, [4S-[4α(S*), 7α, 10aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl) amino]-5-oxo-7H-pyrido[2,1-b][1,3]-thiazepine-7-carboxylic acid.
Claim 12
Dependent Claim
22 words
A compound of claim 6 wherein: r is one, R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 13
Dependent Claim
8 words
The compound of claim 11, [4S-[4α(R*), 7α,10aβ]]-octahydro-4-[[2-(mercaptomethyl)-1-oxo-3-phenylpropyl]amino]-5-oxo-7H-pyrido[2,1-b][1,3]-thiazepine-7-carboxylic acid.
Claim 14
Dependent Claim
22 words
A compound of claim 6 wherein: r is zero; R 2 is hydrogen; R 1 is isobutyl; and R 12 is hydrogen.
Claim 15
Dependent Claim
8 words
The compound of claim 13, [4S-[4α(R*), 7α,10aβ]]-octahydro-4-methyl-1-oxopentyl)amino]-5-oxo-7H-pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid.
Claim 16
Dependent Claim
18 words
A compound of claim 5 wherein: X is S; Y is CH 2 ; and m is zero.
Claim 17
Dependent Claim
33 words
A compound of claim 15 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl, cyclopropylmethyl, n-butyl, isobutyl, n-propyl, --CH 2 --C(CH 3 ) 3 , and R 12 is hydrogen.
Claim 18
Dependent Claim
27 words
The compound of claim 16, [4S-[4α(R*), 7α, 9aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl) amino]-5-oxopyrrolo[2,1-b][1,3]thiazepine-7-carboxylic acid; [4S-[4α(R*),7α, 9aβ]]-octahydro-4-[(3-cyclo-propyl-2-mercapto-1-oxopropyl)amino]-5-oxopyrrolo-[2,1-b][1,3]thiazepine-7-carboxylic acid; [4S-[4α(R*), 7α, 9aβ]]-octahydro-4-[(2-mercapto-1-oxohexyl)amino]-5-oxopyrrolo[2,1-b][1,3]-thiazepine-7-carboxylic acid; [4S-[4α(R*),7α, 9aβ]]-octahydro-4-[(2-mercapto-1-oxo-4-methylpentyl)amino]-5-oxopyrrolo[2,1-b]-[1,3]thiazepine-7-carboxylic acid; [4S-[4α(R*),7α, 9aβ]]-octahydro-4-[(2-mercapto-1-oxopentyl)amino]-5-oxopyrrolo[2,1-b][1,3]-thiazepine-7-carboxylic acid; or [4S-[4α(R*),7α, 9aβ]]-octahydro-4-[(2-mercapto-4,4-dimethyl-1-oxopentyl)amino]-5-oxopyrrolo[2,1-b]-[1,3]thiazepine-7-carboxylic acid.
Claim 19
Dependent Claim
18 words
A compound of claim 5 wherein: X is O; Y is CH 2 ; and m is one.
Claim 20
Dependent Claim
22 words
A compound of claim 18 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 21
Dependent Claim
8 words
The compound of claim 19, [4S-[4α(R*), 7α,10aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl)amino]-5-oxo-7H-pyrido[2,1-b][1,3]oxa-zepine-7-carboxylic acid.
Claim 22
Dependent Claim
18 words
A compound of claim 5 wherein: X is O; Y is CH 2 ; and m is zero.
Claim 23
Dependent Claim
22 words
A compound of claim 21 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 24
Dependent Claim
9 words
The compound of claim 22, [4S-[4α(R*), 7α, 9aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl)amino]-5-oxopyrrolo[2,1-b][1,3]oxa-zepine-7-carboxylic acid.
Claim 25
Dependent Claim
16 words
A compound of claim 5 wherein: X is O; Y is O; and m is one.
Claim 26
Dependent Claim
22 words
A compound of claim 24 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 27
Dependent Claim
8 words
The compound of claim 25, [4S-[4α(R*), 7α,10aβ]]-octahydro,4-[(2-mercapto-1-oxo-3-phenylpropyl)amino]-5-oxo[1,4]oxazino[3,4-b][1,3]-oxazepine-7-carboxylic acid.
Claim 28
Dependent Claim
16 words
A compound of claim 5 wherein: X is S; Y is O; and m is one.
Claim 29
Dependent Claim
22 words
A compound of claim 27 wherein: r is zero; R 2 is hydrogen; R 1 is benzyl; and R 12 is hydrogen.
Claim 30
Dependent Claim
8 words
The compound of claim 28, [4S-[4α(R*), 7α,10aβ]]-octahydro-4-[(2-mercapto-1-oxo-3-phenylpropyl)amino]-5-oxo[1,4]oxazino[3,4-b][1,3]-thiazepine-7-carboxylic acid.
Claim 31
Dependent Claim
52 words
A pharmaceutical composition useful in the treatment of cardiovascular disease such as hypertension and congestive heart failure comprising a pharmaceutically acceptable carrier and one or more compounds of the formula ##STR96## or a pharmaceutically acceptable salt thereof wherein A, X, Y, n, m and R 3 are as defined in claim 1.
Claim 32
Dependent Claim
29 words
A method of treating cardiovascular diseases such as hypertension and congestive heart failure in a mammalian species which comprises administering an effective amount of the composition of claim 30.
Claim 33
Dependent Claim
68 words
A compound of the formula ##STR97## or a salt thereof wherein: X is O or S; n is two; m is zero or one; Y is CH 2 , O or S provided that Y is O or S only when m is one; R 3 is hydrogen, lower alkyl, or aryl --(CH 2 ) p --; and p is zero or an integer from 1 to 6.
Claim 34
Dependent Claim
68 words
A compound of the formula ##STR97## or a salt thereof wherein: X is O or S; n is two; m is zero or one; Y is CH 2 , O or S provided that Y is O or S only when m is one; R 3 is hydrogen, lower alkyl, or aryl --(CH 2 ) p --; and p is zero or an integer from 1 to 6.
Claim 35
Dependent Claim
9 words
A compound of claim 32 having the formula ##STR98##
Claim 36
Dependent Claim
22 words
The compound of claim 33 wherein: X is O; Y is CH 2 ; m is one; and R 3 is methyl.
Claim 37
Dependent Claim
22 words
The compound of claim 33 wherein: X is S; Y is CH 2 ; m is one; and R 3 is methyl.
Claim 38
Dependent Claim
22 words
The compound of claim 33 wherein: X is O; Y is CH 2 ; m is zero; and R 3 is methyl.
Claim 39
Dependent Claim
22 words
The compound of claim 33 wherein: X is S; Y is CH 2 ; m is zero; and R 3 is methyl.
Claim 40
Dependent Claim
20 words
The compound of claim 33 wherein: X is O; Y is O; m is one; and R 3 is methyl.
Claim 41
Dependent Claim
20 words
The compound of claim 33 wherein: X is S; Y is O; m is one; and R 3 is methyl.
References Cited (Backward Citations)
US3856798A
Cited
US4339600A
Cited
US4105776A
Cited
US4186200A
Cited
US4192945A
Cited
US4225495A
Cited
US4374829A
Cited
US4346089A
Cited
US4337201A
Cited
US4415496A
Cited
US4432972A
Cited
US4432971A
Cited
US4873235A
Cited
US5098934A
Cited
US4460579A
Cited
US4711884A
Cited
US4617301A
Cited
US4722810A
Cited
US4584294A
Cited
US4749688A
Cited
US5061710A
Cited
US4801609A
Cited
US4801609B1
Cited
GB2207351A
Cited
US4879309A
Cited
US4879309B1
Cited
US5075302A
Cited
US5190974A
Cited
EP0481522A1
Cited
US5232920A
Cited
EP0524553A1
Cited
EP0534492A2
Cited
EP0534396A2
Cited
EP0534363A2
Cited
WO1993016103A1
Cited
US5208236A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-04-16 | 1999-10-16 | 2000-04-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-04-16 | 2003-10-16 | 2004-04-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-04-16 | 2007-10-16 | 2008-04-16 | $7700.00 | Window Closed / Lapsed |